RET fusion thyroid cancer
Showing 26 - 50 of >10,000
Non Small Cell Lung Cancer, Ovarian Cancer, RET Gene Mutation Trial in New York (RXDX-105)
Completed
- Non Small Cell Lung Cancer
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center 1275 York Avenue
Sep 30, 2020
A Taiwanese Oncogenetic Panel and Integrated Clinical Data
Recruiting
- Thyroid Cancer
- A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
-
Kaohsiung, Taiwan
- +7 more
Sep 12, 2022
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)
Not yet recruiting
- Differentiated Thyroid Cancer
- +3 more
- Larotrectinib monotherapy
- 131I therapy
- (no location specified)
Mar 13, 2023
Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life
Recruiting
- Cancer
- +15 more
- Data collection and quality of life questionnaire
-
Graz, Austria
- +40 more
Jul 27, 2021
Metastic Thyroid Cancer Trial run by the NIDDK (68-Gallium-DOTATATE-PET/CT)
Recruiting
- Metastic Thyroid Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Refractory Solid Tumors Trial in Seoul (sunitinib)
Completed
- Refractory Solid Tumors
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Advanced / Metastic Solid Tumors, Glioblastoma, Chronic Leukemia Lymphocytic Trial in Bron, Lyon (Blood and tumor samples)
Recruiting
- Advanced / Metastic Solid Tumors
- +2 more
- Blood and tumor samples
-
Bron, France
- +1 more
Jun 30, 2022
Oxidative Stress and Mitochondrial TERT in Papillary Thyroid
Recruiting
- Papillary Thyroid Cancer
-
Milan, ItalyIstituto Auxologico Italiano
Mar 2, 2023
Metastatic Sporadic Medullary Thyroid Cancer Patients and
Completed
- Metastatic Sporadic Medullary Thyroid Cancer
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sep 29, 2021
Children and Adults With Medullary Thyroid Cancer
Recruiting
- Medullary Thyroid Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)
Recruiting
- Medullary Thyroid Cancer
- Anlotinib Hydrochloride Capsule
-
Hefei, Anhui, China
- +18 more
Apr 14, 2023
Galectin-3 in Papillary Thyroid Carcinoma
Not yet recruiting
- Galactin 3-thyroid Carcinoma
- (no location specified)
Jan 26, 2023
Low-risk Papillary Thyroid Cancer, Endocrine Malignancy, Thyroid Cancer Trial run by the NCI (Total Thyroidectomy (TT),
Terminated
- Low-risk Papillary Thyroid Cancer
- +2 more
- Total Thyroidectomy (TT)
- Prophylactic central neck lymph node dissection (pCND)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 8, 2022
Papillary Thyroid Tumors by Mass-ARRAY
Recruiting
- Papillary Thyroid Cancer
- Genotyping
-
Milan, MI, ItalyIstituto Auxologico Italiano
Mar 10, 2023
Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)
Enrolling by invitation
- Diabetes
- +3 more
- No treatment given
-
Morgantown, West VirginiaUnited BioSource, LLC
Oct 4, 2022
Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin
Completed
- Medullary Thyroid Carcinoma
- Nodular Goiter
- Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
-
Pilar, Buenos Aires, ArgentinaHospital Universitario Austral
Oct 5, 2023
Breast Cancer Trial in Singapore (Lenvatinib + Letrozole, Fulvestrant)
Not yet recruiting
- Breast Cancer
- Lenvatinib + Letrozole
- Fulvestrant
-
Singapore, SingaporeNationa University Hospital
Jan 4, 2022
Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))
Recruiting
- Solid Tumors Harboring NTRK Fusion
- BAY2757556 (Larotrectinib, Vitrakvi)
-
Palo Alto, California
- +158 more
Aug 8, 2022
Refractory Solid Tumors Trial in Seoul (Sunitinib)
Completed
- Refractory Solid Tumors
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)
Recruiting
- Differentiated Thyroid Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 9, 2023